Macleods levothyroxine sodium 150 mcg tablets recalled for subpotency
Macleods Pharma USA is recalling Levothyroxine Sodium Tablets USP 150 mcg because they may contain less active ingredient than labeled. This means the medication may not work as intended to treat thyroid conditions. The affected lot is 16240062A with an expiration date of March 2026.
From the FDA notice · Read the official notice ↗ · All MacLeods Pharma recalls
What to do
- Stop taking these tablets if you have the affected lot number (16240062A).
- Contact your pharmacy or doctor for a replacement prescription immediately.
- Do not stop your thyroid medication without talking to your doctor first.
- Check your bottle label for lot number 16240062A and NDC 33342-401-44.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 1315 bottles
- Illnesses reported
- None reported
- Manufactured in
- 103 College Rd E Fl 2, Princeton, NJ, United States
- Classification
- Class II
- Recall number
- D-0403-2026
In the FDA's words
- Description
- Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44 Subpotent Drug Lot 16240062A, exp date 3/2026 Distribution: Nationwide Affected quantity: 1315 bottles
- Hazard
- Subpotent Drug
More from MacLeods Pharma
See all- Macleods blood pressure tablets recalled for failed dissolution
ModerateFDAOct 26, 2026